Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-14-003267
Filing Date
2014-04-01
Accepted
2014-04-01 06:02:36
Documents
5
Period of Report
2014-05-06
Effectiveness Date
2014-04-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2219283zdef14a.htm DEF 14A 897172
2 G88932BAI001.GIF g88932bai001.gif GRAPHIC 51434
3 G88932BAI002.GIF g88932bai002.gif GRAPHIC 106459
4 G710737.JPG g710737.jpg GRAPHIC 15257
5 G23096.JPG g23096.jpg GRAPHIC 4108
  Complete submission text file 0001047469-14-003267.txt   1143014
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23272 | Film No.: 14732202
SIC: 2836 Biological Products, (No Diagnostic Substances)